PLAC8 and hepatocellular carcinoma: On the one hand, these fibroblasts, after being activated by HCC cell-derived EVs carrying miR-21, produced CAF-EVs containing miR-1228-3p, which enhanced HCC resistance by targeting PLAC8 and activating the PI3K/Akt signaling pathway (58).